BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 27334276)

  • 1. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
    Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
    Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma.
    Harrabi SB; Bougatf N; Mohr A; Haberer T; Herfarth K; Combs SE; Debus J; Adeberg S
    Strahlenther Onkol; 2016 Nov; 192(11):759-769. PubMed ID: 27363701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
    Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.
    Haefner MF; Verma V; Bougatf N; Mielke T; Tonndorf-Martini E; König L; Rwigema JM; Simone CB; Uhlmann L; Eichhorn F; Winter H; Grosch H; Haberer T; Herfarth K; Debus J; Rieken S
    Acta Oncol; 2018 Dec; 57(12):1713-1720. PubMed ID: 30264630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.
    Stokkevåg CH; Indelicato DJ; Herfarth K; Magelssen H; Evensen ME; Ugland M; Nordberg T; Nystad TA; Hægeland C; Alsaker MD; Ulven K; Dale JE; Engeseth GM; Boer CG; Toussaint L; Kornerup JS; Pettersen HES; Brydøy M; Brandal P; Muren LP
    Acta Oncol; 2019 Oct; 58(10):1416-1422. PubMed ID: 31364899
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving dosimetric outcome for hippocampus and cochlea sparing whole brain radiotherapy using spot-scanning proton arc therapy.
    Ding X; Zhou J; Li X; Blas K; Liu G; Wang Y; Qin A; Chinnaiyan P; Yan D; Stevens C; Grills I; Kabolizadeh P
    Acta Oncol; 2019 Apr; 58(4):483-490. PubMed ID: 30632851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study.
    Mehta P; Janssen S; Fahlbusch FB; Schmid SM; Gebauer J; Cremers F; Ziemann C; Tartz M; Rades D
    BMC Cancer; 2020 Jun; 20(1):610. PubMed ID: 32605648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric modulated arc therapy (VMAT) for hippocampal-avoidance whole brain radiation therapy: planning comparison with Dual-arc and Split-arc partial-field techniques.
    Yuen AHL; Wu PM; Li AKL; Mak PCY
    Radiat Oncol; 2020 Feb; 15(1):42. PubMed ID: 32070385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclined head position improves dose distribution during hippocampal-sparing whole brain radiotherapy using VMAT.
    Kim KS; Seo SJ; Lee J; Seok JY; Hong JW; Chung JB; Kim E; Choi N; Eom KY; Kim JS; Kim IA
    Strahlenther Onkol; 2016 Jul; 192(7):473-80. PubMed ID: 27221313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation therapy and volumetric-modulated arc therapy for adult craniospinal irradiation--a comparison with traditional techniques.
    Studenski MT; Shen X; Yu Y; Xiao Y; Shi W; Biswas T; Werner-Wasik M; Harrison AS
    Med Dosim; 2013; 38(1):48-54. PubMed ID: 22878118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single arc volumetric modulated arc therapy for complex brain gliomas: is there an advantage as compared to intensity modulated radiotherapy or by adding a partial arc?
    Davidson MT; Masucci GL; Follwell M; Blake SJ; Xu W; Moseley DJ; Sanghera P; Wong CS; Perry J; Tsao M; Sahgal A
    Technol Cancer Res Treat; 2012 Jun; 11(3):211-20. PubMed ID: 22376134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial.
    Eekers DBP; Roelofs E; Cubillos-Mesías M; Niël C; Smeenk RJ; Hoeben A; Minken AWH; Granzier M; Janssens GO; Kaanders JHAM; Lambin P; Troost EGC
    Acta Oncol; 2019 Jan; 58(1):57-65. PubMed ID: 30474448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
    Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
    Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric advantage of intensity-modulated radiotherapy for whole ventricles in the treatment of localized intracranial germinoma.
    Sakanaka K; Mizowaki T; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e273-80. PubMed ID: 21640515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is high-dose rate RapidArc-based radiosurgery dosimetrically advantageous for the treatment of intracranial tumors?
    Zhao B; Yang Y; Li X; Li T; Heron DE; Saiful Huq M
    Med Dosim; 2015; 40(1):3-8. PubMed ID: 25645205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
    Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
    Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coplanar volumetric-modulated arc therapy (VMAT) for craniopharyngiomas reduces radiation doses to the bilateral hippocampus: a planning study comparing dynamic conformal arc therapy, coplanar VMAT, and non-coplanar VMAT.
    Uto M; Mizowaki T; Ogura K; Hiraoka M
    Radiat Oncol; 2016 Jun; 11():86. PubMed ID: 27338798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric-modulated arc therapy (VMAT) for whole brain radiotherapy: not only for hippocampal sparing, but also for reduction of dose to organs at risk.
    Sood S; Pokhrel D; McClinton C; Lominska C; Badkul R; Jiang H; Wang F
    Med Dosim; 2017 Winter; 42(4):375-383. PubMed ID: 28822604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative treatment planning study for mediastinal Hodgkin's lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy.
    Edvardsson A; Kügele M; Alkner S; Enmark M; Nilsson J; Kristensen I; Kjellén E; Engelholm S; Ceberg S
    Acta Oncol; 2019 Jan; 58(1):95-104. PubMed ID: 30280626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.